Affiliation:
1. Phytomedicine, Biochemical Toxicology and Diabetes Research Group, Department of Biochemistry , Afe Babalola University , Ado-Ekiti , Ekiti State, Nigeria
2. Department of Medical Biochemistry , Afe Babalola University , Ado-Ekiti , Ekiti State, Nigeria
Abstract
Abstract
Objectives: Inflammation plays a crucial role in many of the metabolic abnormalities. The prototypic marker of inflammation is C-reactive protein (CRP), Nitric Oxide (NO), inducible nitric oxide synthase (iNOS) and their inhibition is considered a promising strategy to combat inflammation. Here, we report the anti-inflammatory mechanism of Carica papaya root aqueous extract in sodium arsenic-induced renal dysfunction.
Methodology: Thirty-five rats were used for the experiments. Griess assay was used to evaluate the inhibitory effect of Carica papaya roots aqueous extract on the overproduction of nitric oxide (NO). ELISA was used to determine the level of pro-inflammatory markers including c-reactive protein (CRP). ELISA was used to analyze 8-OHdG. The inhibitory effect on the enzymatic activity of inducible nitric oxide synthase (iNOS), adenosine deaminase (ADA), malondialdehyde (MDA) was tested by enzyme activity assay kits.
Results:
Carica papaya roots aqueous extract suppressed sodium arsenite-stimulated NO production and proinflammatory secretion, such as CRP. Carica papaya roots aqueous extract significantly (p < 0.05) decrease the activities of iNOS, 8-OHdG, ADA and MDA.
Conclusion: These results indicated that potent inhibition on CRP, NO, iNOS, ADA, 8-OHdG might constitute the anti-inflammatory mechanism of Carica papaya roots aqueous extract.
Reference48 articles.
1. 1. IARC (International Agency for Research on Cancer). Monographs on evaluation of carcinogenic risk to humans. In: Some Drinking Water Disinfectants and Contaminants, including Arsenic. 2004; 84: 269–477.
2. 2. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Arsenic TP-92/09, Center for Disease Control, Atlanta, Georgia, 2000.
3. 3. Vahter M, Concha G (2001) Role of metabolism in arsenic toxicity. Pharmacol Toxicol. 2001; 89 (1): 1–5.
4. 4. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenic acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol. 2004; 198 (3):394–404.
5. 5. Tchounwou PB, Centeno JA, Patlolla AK. Arsenic toxicity, mutagenesis, and carcinogenesis — a health risks assessment and management approach. Mol Cell Biochem. 2004; 255(1-2): 47–55.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献